Lv3
244 积分 2024-01-08 加入
Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis
1个月前
已完结
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions
1个月前
已完结
Immune checkpoint inhibition in upper tract urothelial carcinoma
1个月前
已完结
Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies
1个月前
已完结
Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art
1个月前
已完结
Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
1个月前
已完结
Efficacy and safety of disitamab vedotin (RC48) combined with toripalimab as adjuvant therapy after radical surgery for patients with HER2-overexpression upper tract urothelial cancer (UTUC): A single-arm, prospective, phase 2 clinical trial
1个月前
已关闭
A0586 – Tumor-informed minimal residual disease (MRD) detection in blood and urine predicts recurrence and metastasis in patients with surgically cured upper tract urothelial carcinoma (UTUC): A prospective cohort study
1个月前
已关闭
Dynamic Precision Oncology for Real-Time Molecular Monitoring and Management in Urothelial Carcinoma
1个月前
已完结
A0582 Circulating and urine tumor DNA dynamics predict minimal residual disease and recurrence risk in locally advanced Upper Tract Urothelial Carcinoma (CURATEUTUC): A multicenter prospective longitudinal cohort study
1个月前
已关闭
皖公网安备34019202002308
